TY - JOUR
T1 - Palliative care and end-stage liver disease
T2 - A critical review of current knowledge
AU - Rakoski, Mina O.
AU - Volk, Michael L.
N1 - Publisher Copyright:
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Purpose of review End-stage liver disease (ESLD) is associated with high symptom burden, poor quality of life, and significant healthcare costs. Palliative care, which is not synonymous with hospice or end-of-life care, is a multidisciplinary model of care that focuses on patient-centered goals with the intent of improving quality of life and reducing suffering. This review will summarize current literature supporting the benefits of early integration of palliative care in patients in this population. Recent findings Advance care planning (ACP) and goals of care discussions have been associated with improved quality of life, decreased anxiety, and improved satisfaction with care for both the patient and the caregiver. These discussions are beneficial to all patients with ESLD, including those listed for liver transplantation. Summary Despite the resounding benefits of palliative care for patients with other advanced diseases, palliative care remains underutilized in liver disease. There is an urgent need for education of hepatology/transplant providers as well as development of society guidelines to help dissemination and acceptability of palliative care for patients with ESLD.
AB - Purpose of review End-stage liver disease (ESLD) is associated with high symptom burden, poor quality of life, and significant healthcare costs. Palliative care, which is not synonymous with hospice or end-of-life care, is a multidisciplinary model of care that focuses on patient-centered goals with the intent of improving quality of life and reducing suffering. This review will summarize current literature supporting the benefits of early integration of palliative care in patients in this population. Recent findings Advance care planning (ACP) and goals of care discussions have been associated with improved quality of life, decreased anxiety, and improved satisfaction with care for both the patient and the caregiver. These discussions are beneficial to all patients with ESLD, including those listed for liver transplantation. Summary Despite the resounding benefits of palliative care for patients with other advanced diseases, palliative care remains underutilized in liver disease. There is an urgent need for education of hepatology/transplant providers as well as development of society guidelines to help dissemination and acceptability of palliative care for patients with ESLD.
KW - advance care planning
KW - cirrhosis
KW - end-stage liver disease
KW - palliative care
UR - http://www.scopus.com/inward/record.url?scp=85064286954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064286954&partnerID=8YFLogxK
U2 - 10.1097/MOG.0000000000000530
DO - 10.1097/MOG.0000000000000530
M3 - Review article
C2 - 30925536
SN - 0267-1379
VL - 35
SP - 155
EP - 160
JO - Current Opinion in Gastroenterology
JF - Current Opinion in Gastroenterology
IS - 3
ER -